Anne C. Chiang

机构：Yale Cancer Center, Yale University · ORCID：0000-0002-2111-4694

发表论文 188 篇 · 总被引 10403 次 · h-index 29

代表论文

• Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03 (2025 · Journal of Thoracic Oncology · 被引 51)
• Top advances of the year: Small cell lung cancer (2025 · Cancer · 被引 19)
• Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma (2025 · Nature Communications · 被引 13)
• Safety and efficacy of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in high-grade neuroendocrine neoplasms. (2025 · Journal of Clinical Oncology · 被引 9)
• OA06.04 Safety and Efficacy of ABBV-706, a Seizure-related Homolog Protein 6-targeting Antibody-drug Conjugate, in R/R SCLC (2025 · Journal of Thoracic Oncology · 被引 7)
• Molecular Biomarker Testing Patterns and Turnaround Time in US Patients With Advanced Non–Small Cell Lung Cancer (2025 · Journal of the National Comprehensive Cancer Network · 被引 4)